Each filer's latest filing for 871332102 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
ACR Group Paper Holdings LP
13D/A
|
15.6% |
11/6/2025
Event 11/5/2025
|
||
| ACR Group Paper Holdings JR LP | 15.6% | |||
| ACR Group Paper Holdings JR GP LLC | 15.6% | |||
| ACR Group Paper Holdings LP | 15.6% | |||
| Atlas Capital GP IV LP | 15.6% | |||
| Atlas Capital Resources GP IV LLC | 15.6% | |||
| Atlas GP Global Holdings LLC | 15.6% | |||
| Andrew M. Bursky | 15.6% | |||
| Timothy J. Fazio | 15.6% | |||
|
Integrated Core Strategies (US) LLC
13G
|
5.4% |
11/24/2025
Event 11/18/2025
|
||
| Integrated Core Strategies (US) LLC | 5.4% | |||
| Millennium Management LLC | 5.4% | |||
| Millennium Group Management LLC | 5.4% | |||
| Israel A. Englander | 5.4% | |||
|
American Century Investment Management, Inc.
13G
|
5.3% |
11/16/2026
Event 9/30/2026
|
||
| American Century ETF Trust | 5.1% | |||
| American Century Investment Management, Inc. | 5.3% | |||
| American Century Companies, Inc. | 5.3% | |||
| Stowers Institute for Medical Research | 5.3% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
|
Nomura Holdings Inc
13G/A
|
4.0% |
8/14/2025
Event 6/30/2025
|
||
| Nomura Holdings Inc | 4.0% | |||
| Nomura Global Financial Products Inc | 4.0% | |||
| Vanguard Group Inc 13G/A | 0% |
3/27/2026
Event 3/13/2026
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 306 | 40.4 M | $1.32B |
| 2026 Q2 | 338 | 39.7 M | $1.50B |
| 2026 Q1 | 327 | 39.8 M | $1.68B |
| 2025 Q4 | 363 | 39.7 M | $1.91B |
| 2025 Q3 | 350 | 37.5 M | $1.66B |
| 2025 Q2 | 380 | 36.7 M | $1.84B |
| 2025 Q1 | 393 | 38.5 M | $2.59B |
| 2024 Q4 | 405 | 39.1 M | $3.09B |
| 2024 Q3 | 403 | 38.9 M | $3.34B |
| 2024 Q2 | 383 | 38.3 M | $2.63B |
| 2024 Q1 | 357 | 37.7 M | $2.33B |
| 2023 Q4 | 329 | 37.5 M | $1.84B |
| 2023 Q3 | 320 | 38.7 M | $1.70B |
| 2023 Q2 | 331 | 38.2 M | $1.54B |
| 2023 Q1 | 359 | 38.3 M | $1.77B |
| 2022 Q4 | 369 | 37.2 M | $1.81B |
| 2022 Q3 | 346 | 38.3 M | $1.30B |
| 2022 Q2 | 351 | 35.0 M | $1.15B |
| 2022 Q1 | 325 | 28.8 M | $960M |
| 2021 Q4 | 382 | 27.3 M | $764M |
| 2021 Q3 | 24 | 1.15 M | $37.6M |